RxDoctor Payments Data

Domingo Perez, MD

Cardiovascular Disease · Bayamon, PRNPI 1154343978

Payments from drug & device makers

$4,969in general payments, 2019–2025

Across 138 payments — averaging $36.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$932
  • Amgen$743
  • E.r. Squibb & Sons, L.L.C.$541
  • AstraZeneca$497
  • Boehringer Ingelheim$458
  • PBG Puerto Rico LLC$353
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,88598%
  • Education$842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson25$932
Amgen11$743
E.r. Squibb & Sons, L.L.C.19$541
AstraZeneca15$497
Boehringer Ingelheim15$458
PBG Puerto Rico LLC17$353
Medtronic(2 entities)3$340
Merck6$282
Boston Scientific3$250
Bayer6$149
Lilly USA, LLC1$113
Novartis4$95
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)6$60
Pfizer Pharmaceuticals LLC2$45
Abbott2$37
Pfizer1$35
Eli Lilly Export S.A. Puerto Rico Branch1$20
AbbVie1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,969 in reported general payments places this provider in the 60th percentile of 267 cardiovascular disease providers in Puerto Rico.

See all cardiovascular disease providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$10,957
Medicare patients
41
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban175$176,524
XareltoRivaroxaban122$104,398
EntrestoSacubitril/Valsartan81$73,906
Repatha SureclickEvolocumab57$50,435
FarxigaDapagliflozin Propanediol37$42,881
JardianceEmpagliflozin38$35,273
BrilintaTicagrelor27$30,328
Candesartan Cilexetil128$16,512
Janumet XrSitagliptin Phos/Metformin Hcl21$16,240
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid66$12,955
SynthroidLevothyroxine Sodium91$11,656
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide207$11,555
Metoprolol Succinate532$11,348
Irbesartan263$9,897
Atorvastatin Calcium442$6,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$35$176,524175 claims
Johnson & JohnsonXarelto$932$104,398122 claims
NovartisEntresto$95$73,90681 claims
AstraZenecaFarxiga, Brilinta$497$73,20964 claims
Boehringer IngelheimJardiance$458$35,27338 claims
MerckJanumet Xr$282$16,24021 claims
AbbVieSynthroid$19$11,65691 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 267 cardiovascular disease providers in Puerto Rico.

Other cardiovascular disease in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →